- Stocks
- Financials
- Zenlabs Ethica
Zenlabs Ethica share price
NSE: ZENLABSFinancialsMedical Distribution
Zenlabs Ethica at a glance
With a market capitalisation of ₹22 Cr, it ranks 3547th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Financials sector; its industry is Medical Distribution.
Its return on equity was −22.7% in FY26. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹429 Cr (−14.0% year on year) and net profit −₹20 Cr (−126.5%), on a consolidated basis. Promoters held 52.96% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹22 CrRank 3547 on NSE
- Price to book
- 1.33×FY26
- EPS (TTM)
- −₹1.46to Q1 FY27
- ROE
- −22.7%FY26
- ROCE
- 10.7%FY26
- Net profit margin
- −4.1%FY26
- Book value / share
- ₹13.08FY26
Returns to 19 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
Zenlabs Ethica quarterly results
| Quarter | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹319 Cr | ₹535 Cr | ₹520 Cr | ₹499 Cr | ₹526 Cr | ₹406 Cr | ₹398 Cr | ₹429 Cr |
| Revenue YoY | +7.3% | +66.9% | +95.4% | +99.4% | +65.1% | −24.1% | −23.5% | −14.0% |
| Net profit | ₹17 Cr | ₹14 Cr | ₹10 Cr | ₹76 Cr | ₹190 Cr | ₹9 Cr | ₹86 Cr | −₹20 Cr |
| Net profit YoY | −27.8% | −52.5% | +334.7% | +211.2% | +986.1% | −36.8% | +805.7% | −126.5% |
| Net margin | 5.5% | 2.6% | 1.8% | 15.2% | 36.0% | 2.2% | 21.7% | −4.7% |
| EPS | ₹3.11 | ₹3.84 | ₹0.22 | ₹6.04 | −₹0.84 | ₹0.27 | ₹1.27 | −₹2.16 |
Zenlabs Ethica financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Revenue | ₹57 Cr | ₹69 Cr | ₹67 Cr | ₹59 Cr | ₹51 Cr | — |
| Operating profit | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | — |
| Net profit | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | — |
| EPS (₹) | ₹1.41 | ₹1.26 | ₹0.75 | ₹0.65 | ₹0.41 | — |
| Cash from operations | ₹0 Cr | −₹0 Cr | ₹2 Cr | −₹9 Cr | ₹4 Cr | — |
| Total debt | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Shareholders' equity | ₹8 Cr | ₹9 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹9 Cr |
Zenlabs Ethica shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 52.96% | 52.96% | 52.96% | 52.96% | 52.96% | 52.96% |
| Non-institutions | 47.04% | 47.04% | 47.04% | 47.04% | 47.04% | 47.04% |
Zenlabs Ethica vs peers
The listed Financials companies nearest to Zenlabs Ethica by market capitalisation.
Ask anything about Zenlabs Ethica
Pivot answers on the live chart with evidence you can check, and tests strategies against ZENLABS's own history. Try: “Why has ZENLABS moved over the last three months?” · “Backtest a 50-day moving-average crossover on ZENLABS over five years” · “Compare ZENLABS with ADCON on margins and valuation”
Frequently asked questions about Zenlabs Ethica
What is the market cap of Zenlabs Ethica?
Zenlabs Ethica's market capitalisation is ₹22 Cr (₹22 Cr) at the 19 Oct 2026 close, ranking 3547th among the NSE companies Pivot tracks.
What is the ROE and ROCE of Zenlabs Ethica?
Return on equity was −22.7% in FY26 and return on capital employed was 10.7% in FY26 (standalone figures).
What were Zenlabs Ethica's latest quarterly results?
For Q1 FY27 (quarter ended 30 Jun 2026), Zenlabs Ethica reported revenue of ₹429 Cr, −14.0% year on year, and net profit of −₹20 Cr, −126.5% year on year.
What is the shareholding pattern of Zenlabs Ethica?
As of 30 Jun 2026: promoters 52.96%, non-institutions 47.04%.
Who are Zenlabs Ethica's competitors?
The listed Financials companies closest to Zenlabs Ethica by market cap are Adcon Capital, Helpage Fin, KJMC Corporate, Navigant Corp., Shricon Ind and TTI Enterprise.
Is Zenlabs Ethica a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Zenlabs Ethica's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on ZENLABS against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 19 Oct 2026 (returns and ratios at the 19 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Financials stocks · companies starting with Z · all NSE stocks · this page as text